These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 33810837)

  • 41. Dysregulation of AMPA receptor subunit expression in sporadic ALS post-mortem brain.
    Gregory JM; Livesey MR; McDade K; Selvaraj BT; Barton SK; Chandran S; Smith C
    J Pathol; 2020 Jan; 250(1):67-78. PubMed ID: 31579943
    [TBL] [Abstract][Full Text] [Related]  

  • 42. De novo FUS mutations are the most frequent genetic cause in early-onset German ALS patients.
    Hübers A; Just W; Rosenbohm A; Müller K; Marroquin N; Goebel I; Högel J; Thiele H; Altmüller J; Nürnberg P; Weishaupt JH; Kubisch C; Ludolph AC; Volk AE
    Neurobiol Aging; 2015 Nov; 36(11):3117.e1-3117.e6. PubMed ID: 26362943
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Screening for TARDBP mutations in Japanese familial amyotrophic lateral sclerosis.
    Kamada M; Maruyama H; Tanaka E; Morino H; Wate R; Ito H; Kusaka H; Kawano Y; Miki T; Nodera H; Izumi Y; Kaji R; Kawakami H
    J Neurol Sci; 2009 Sep; 284(1-2):69-71. PubMed ID: 19411082
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Genetics of amyotrophic lateral sclerosis].
    Weber S; Corcia P; Viader F
    Rev Prat; 2023 Sep; 73(7):783-787. PubMed ID: 37796272
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Update on amyotrophic lateral sclerosis genetics.
    Brenner D; Weishaupt JH
    Curr Opin Neurol; 2019 Oct; 32(5):735-739. PubMed ID: 31335339
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Metal(loid)s role in the pathogenesis of amyotrophic lateral sclerosis: Environmental, epidemiological, and genetic data.
    Tesauro M; Bruschi M; Filippini T; D'Alfonso S; Mazzini L; Corrado L; Consonni M; Vinceti M; Fusi P; Urani C
    Environ Res; 2021 Jan; 192():110292. PubMed ID: 33027627
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Novel optineurin mutations in patients with familial and sporadic amyotrophic lateral sclerosis.
    Del Bo R; Tiloca C; Pensato V; Corrado L; Ratti A; Ticozzi N; Corti S; Castellotti B; Mazzini L; Sorarù G; Cereda C; D'Alfonso S; Gellera C; Comi GP; Silani V;
    J Neurol Neurosurg Psychiatry; 2011 Nov; 82(11):1239-43. PubMed ID: 21613650
    [TBL] [Abstract][Full Text] [Related]  

  • 48. VCP mutations in familial and sporadic amyotrophic lateral sclerosis.
    Koppers M; van Blitterswijk MM; Vlam L; Rowicka PA; van Vught PW; Groen EJ; Spliet WG; Engelen-Lee J; Schelhaas HJ; de Visser M; van der Kooi AJ; van der Pol WL; Pasterkamp RJ; Veldink JH; van den Berg LH
    Neurobiol Aging; 2012 Apr; 33(4):837.e7-13. PubMed ID: 22078486
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Genetics of amyotrophic lateral sclerosis].
    Corcia P; Blasco H; Camu W
    Presse Med; 2014 May; 43(5):555-62. PubMed ID: 24703222
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Impact of C9orf72 on Japanese Patients with Amytrophic Lateral Sclerosis (ALS)/Frontotemporal Dementia (FTD)].
    Tomiyama H
    Brain Nerve; 2019 Nov; 71(11):1190-1208. PubMed ID: 31722305
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical and neuropathological features of ALS/FTD with TIA1 mutations.
    Hirsch-Reinshagen V; Pottier C; Nicholson AM; Baker M; Hsiung GR; Krieger C; Sengdy P; Boylan KB; Dickson DW; Mesulam M; Weintraub S; Bigio E; Zinman L; Keith J; Rogaeva E; Zivkovic SA; Lacomis D; Taylor JP; Rademakers R; Mackenzie IRA
    Acta Neuropathol Commun; 2017 Dec; 5(1):96. PubMed ID: 29216908
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Novel and Recurrent Mutations in a Cohort of Chinese Patients With Young-Onset Amyotrophic Lateral Sclerosis.
    Deng J; Wu W; Xie Z; Gang Q; Yu M; Liu J; Wang Q; Lv H; Zhang W; Huang Y; Wang T; Yuan Y; Hong D; Wang Z
    Front Neurosci; 2019; 13():1289. PubMed ID: 31866807
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Optineurin in patients with Amyotrophic Lateral Sclerosis associated to atypical Parkinsonism in Tunisian population.
    Kacem I; Sghaier I; Peverelli S; Abida Y; Ben Brahim H; Ratti A; Nasri A; Ticozzi N; Silani V; Gouider R
    Amyotroph Lateral Scler Frontotemporal Degener; 2024 Feb; 25(1-2):128-134. PubMed ID: 37904275
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comprehensive analysis of the mutation spectrum in 301 German ALS families.
    Müller K; Brenner D; Weydt P; Meyer T; Grehl T; Petri S; Grosskreutz J; Schuster J; Volk AE; Borck G; Kubisch C; Klopstock T; Zeller D; Jablonka S; Sendtner M; Klebe S; Knehr A; Günther K; Weis J; Claeys KG; Schrank B; Sperfeld AD; Hübers A; Otto M; Dorst J; Meitinger T; Strom TM; Andersen PM; Ludolph AC; Weishaupt JH;
    J Neurol Neurosurg Psychiatry; 2018 Aug; 89(8):817-827. PubMed ID: 29650794
    [TBL] [Abstract][Full Text] [Related]  

  • 55. SOD1, ANG, VAPB, TARDBP, and FUS mutations in familial amyotrophic lateral sclerosis: genotype-phenotype correlations.
    Millecamps S; Salachas F; Cazeneuve C; Gordon P; Bricka B; Camuzat A; Guillot-Noël L; Russaouen O; Bruneteau G; Pradat PF; Le Forestier N; Vandenberghe N; Danel-Brunaud V; Guy N; Thauvin-Robinet C; Lacomblez L; Couratier P; Hannequin D; Seilhean D; Le Ber I; Corcia P; Camu W; Brice A; Rouleau G; LeGuern E; Meininger V
    J Med Genet; 2010 Aug; 47(8):554-60. PubMed ID: 20577002
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Targeted high-throughput sequencing identifies a TARDBP mutation as a cause of early-onset FTD without motor neuron disease.
    Synofzik M; Born C; Rominger A; Lummel N; Schöls L; Biskup S; Schüle C; Grasshoff U; Klopstock T; Adamczyk C
    Neurobiol Aging; 2014 May; 35(5):1212.e1-5. PubMed ID: 24300238
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Delineating the genetic heterogeneity of ALS using targeted high-throughput sequencing.
    Kenna KP; McLaughlin RL; Byrne S; Elamin M; Heverin M; Kenny EM; Cormican P; Morris DW; Donaghy CG; Bradley DG; Hardiman O
    J Med Genet; 2013 Nov; 50(11):776-83. PubMed ID: 23881933
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Analysis of known amyotrophic lateral sclerosis and frontotemporal dementia genes reveals a substantial genetic burden in patients manifesting both diseases not carrying the
    Dols-Icardo O; García-Redondo A; Rojas-García R; Borrego-Hernández D; Illán-Gala I; Muñoz-Blanco JL; Rábano A; Cervera-Carles L; Juárez-Rufián A; Spataro N; De Luna N; Galán L; Cortes-Vicente E; Fortea J; Blesa R; Grau-Rivera O; Lleó A; Esteban-Pérez J; Gelpi E; Clarimón J
    J Neurol Neurosurg Psychiatry; 2018 Feb; 89(2):162-168. PubMed ID: 28889094
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Ethical considerations in the management of amyotrophic lateral sclerosis.
    Eisen A; Krieger C
    Prog Neurobiol; 2013 Nov; 110():45-53. PubMed ID: 23735671
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Amyotrophic Lateral Sclerosis and Frontotemporal Lobar Degenerations: Similarities in Genetic Background.
    Parobkova E; Matej R
    Diagnostics (Basel); 2021 Mar; 11(3):. PubMed ID: 33805659
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.